Hip arthroplasty infection with heterogeneous vancomycin-resistant Staphylococcus aureus

Area of Science:

• Orthopedic Surgery
• Infectious Diseases
• Pharmacology

Background:

• Hip arthroplasty infections pose significant challenges, particularly those caused by antibiotic-resistant bacteria.
• Vancomycin-resistant Staphylococcus aureus (VRSA) presents a critical threat in orthopedic implant infections.

Observation:

• A patient presented with a heterogeneous VRSA infection of a hip arthroplasty.
• Initial presentation suggested a difficult-to-treat scenario due to antibiotic resistance.

Findings:

• Surgical intervention involving debridement and removal of prosthetic components was performed.
• Prolonged, high-dose intravenous vancomycin therapy, administered continuously and closely monitored, achieved an apparent cure.
• Heterogeneous resistance patterns in VRSA can impact treatment strategies.

Implications:

• This case highlights the potential efficacy of aggressive surgical and antibiotic management for complex VRSA hip arthroplasty infections.
• Optimized vancomycin dosing and continuous infusion may be crucial for eradicating resistant organisms in prosthetic joint infections.
• Further research into managing heterogeneous VRSA in orthopedic settings is warranted.